

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | glycosphingolipid catabolic process (GO:0046479) | 4.14715117 |
| 2 | oligosaccharide catabolic process (GO:0009313) | 3.99147245 |
| 3 | apoptotic cell clearance (GO:0043277) | 3.82788654 |
| 4 | glycolipid catabolic process (GO:0019377) | 3.72917918 |
| 5 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.69173096 |
| 6 | detection of molecule of bacterial origin (GO:0032490) | 3.63067497 |
| 7 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.58772355 |
| 8 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.58772355 |
| 9 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.58772355 |
| 10 | modulation by symbiont of host immune response (GO:0052553) | 3.58772355 |
| 11 | positive regulation by symbiont of host defense response (GO:0052509) | 3.58772355 |
| 12 | modulation by symbiont of host defense response (GO:0052031) | 3.58772355 |
| 13 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.55047936 |
| 14 | Golgi transport vesicle coating (GO:0048200) | 3.51470204 |
| 15 | COPI coating of Golgi vesicle (GO:0048205) | 3.51470204 |
| 16 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.48284766 |
| 17 | low-density lipoprotein particle clearance (GO:0034383) | 3.45818698 |
| 18 | barbed-end actin filament capping (GO:0051016) | 3.41506184 |
| 19 | protein carboxylation (GO:0018214) | 3.38132745 |
| 20 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.38132745 |
| 21 | response to peptidoglycan (GO:0032494) | 3.34781546 |
| 22 | alpha-linolenic acid metabolic process (GO:0036109) | 3.25132208 |
| 23 | ceramide catabolic process (GO:0046514) | 3.22422507 |
| 24 | mannose metabolic process (GO:0006013) | 3.19975095 |
| 25 | regulation of cholesterol storage (GO:0010885) | 3.16851696 |
| 26 | macrophage activation involved in immune response (GO:0002281) | 3.13023849 |
| 27 | negative regulation of interleukin-12 production (GO:0032695) | 3.07931573 |
| 28 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.03397143 |
| 29 | amino sugar catabolic process (GO:0046348) | 3.01641418 |
| 30 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.01391880 |
| 31 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.96749512 |
| 32 | complement activation, alternative pathway (GO:0006957) | 2.96167634 |
| 33 | peptide catabolic process (GO:0043171) | 2.95674639 |
| 34 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.94299291 |
| 35 | L-phenylalanine catabolic process (GO:0006559) | 2.94299291 |
| 36 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.94033484 |
| 37 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.93800754 |
| 38 | response to thyroid hormone (GO:0097066) | 2.93506214 |
| 39 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.92676291 |
| 40 | plasma lipoprotein particle clearance (GO:0034381) | 2.91823696 |
| 41 | pinocytosis (GO:0006907) | 2.89754164 |
| 42 | positive regulation of receptor recycling (GO:0001921) | 2.89040750 |
| 43 | macroautophagy (GO:0016236) | 2.88267800 |
| 44 | regulation of mononuclear cell migration (GO:0071675) | 2.86694138 |
| 45 | regulation of cholesterol homeostasis (GO:2000188) | 2.86267541 |
| 46 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.86132130 |
| 47 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.85968207 |
| 48 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.83913998 |
| 49 | L-phenylalanine metabolic process (GO:0006558) | 2.83913998 |
| 50 | phospholipid homeostasis (GO:0055091) | 2.83517650 |
| 51 | adhesion of symbiont to host (GO:0044406) | 2.82867453 |
| 52 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.79104666 |
| 53 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.78862930 |
| 54 | regulation of protein activation cascade (GO:2000257) | 2.77587318 |
| 55 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.77171391 |
| 56 | iron ion import (GO:0097286) | 2.77080047 |
| 57 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.76432337 |
| 58 | regulation of complement activation (GO:0030449) | 2.75444534 |
| 59 | detection of external biotic stimulus (GO:0098581) | 2.74625118 |
| 60 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.71656834 |
| 61 | negative regulation of fibrinolysis (GO:0051918) | 2.70973286 |
| 62 | virion attachment to host cell (GO:0019062) | 2.70376775 |
| 63 | adhesion of symbiont to host cell (GO:0044650) | 2.70376775 |
| 64 | neutrophil activation involved in immune response (GO:0002283) | 2.70205260 |
| 65 | cell adhesion mediated by integrin (GO:0033627) | 2.69992610 |
| 66 | positive regulation of p38MAPK cascade (GO:1900745) | 2.66866073 |
| 67 | amyloid precursor protein catabolic process (GO:0042987) | 2.66423399 |
| 68 | lysine catabolic process (GO:0006554) | 2.65944325 |
| 69 | lysine metabolic process (GO:0006553) | 2.65944325 |
| 70 | response to laminar fluid shear stress (GO:0034616) | 2.65914486 |
| 71 | positive regulation of leukocyte degranulation (GO:0043302) | 2.65891192 |
| 72 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.63921109 |
| 73 | hyaluronan catabolic process (GO:0030214) | 2.63552381 |
| 74 | sulfur amino acid catabolic process (GO:0000098) | 2.62451093 |
| 75 | reverse cholesterol transport (GO:0043691) | 2.60476399 |
| 76 | cellular extravasation (GO:0045123) | 2.58530408 |
| 77 | membrane lipid catabolic process (GO:0046466) | 2.58122871 |
| 78 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.57835343 |
| 79 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.56914881 |
| 80 | positive regulation of interferon-alpha production (GO:0032727) | 2.56828175 |
| 81 | positive regulation of nuclease activity (GO:0032075) | 2.56700733 |
| 82 | positive regulation of cholesterol efflux (GO:0010875) | 2.55686012 |
| 83 | 4-hydroxyproline metabolic process (GO:0019471) | 2.53363421 |
| 84 | sphingolipid catabolic process (GO:0030149) | 2.51857852 |
| 85 | urea cycle (GO:0000050) | 2.51758984 |
| 86 | urea metabolic process (GO:0019627) | 2.51758984 |
| 87 | detection of other organism (GO:0098543) | 2.51016108 |
| 88 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.50603662 |
| 89 | * keratan sulfate catabolic process (GO:0042340) | 2.50430120 |
| 90 | lipoprotein metabolic process (GO:0042157) | 2.48101975 |
| 91 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.47116420 |
| 92 | phospholipid efflux (GO:0033700) | 2.47033673 |
| 93 | cysteine metabolic process (GO:0006534) | 2.46071467 |
| 94 | aromatic amino acid family catabolic process (GO:0009074) | 2.45690085 |
| 95 | cellular modified amino acid catabolic process (GO:0042219) | 2.45426930 |
| 96 | regulation of macrophage chemotaxis (GO:0010758) | 2.45145591 |
| 97 | positive regulation of fatty acid oxidation (GO:0046321) | 2.43754187 |
| 98 | microglial cell activation (GO:0001774) | 2.41986486 |
| 99 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.41677936 |
| 100 | high-density lipoprotein particle remodeling (GO:0034375) | 2.41549974 |
| 101 | regulation of interferon-alpha production (GO:0032647) | 2.41162686 |
| 102 | homocysteine metabolic process (GO:0050667) | 2.40384245 |
| 103 | skin morphogenesis (GO:0043589) | 2.40339196 |
| 104 | negative regulation of lipid storage (GO:0010888) | 2.39868238 |
| 105 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.39563521 |
| 106 | positive regulation of lipid catabolic process (GO:0050996) | 2.38832498 |
| 107 | cellular response to unfolded protein (GO:0034620) | 2.37417208 |
| 108 | stress fiber assembly (GO:0043149) | 2.37371383 |
| 109 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.37141138 |
| 110 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.37141138 |
| 111 | cholesterol efflux (GO:0033344) | 2.36890083 |
| 112 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.36450760 |
| 113 | endodermal cell differentiation (GO:0035987) | 2.35349050 |
| 114 | regulation of leukocyte degranulation (GO:0043300) | 2.34695025 |
| 115 | growth hormone receptor signaling pathway (GO:0060396) | 2.34591010 |
| 116 | lipoprotein transport (GO:0042953) | 2.34494193 |
| 117 | detection of biotic stimulus (GO:0009595) | 2.34296290 |
| 118 | ER-nucleus signaling pathway (GO:0006984) | 2.33892338 |
| 119 | N-acetylneuraminate metabolic process (GO:0006054) | 2.33580432 |
| 120 | positive regulation of hemostasis (GO:1900048) | 2.33517200 |
| 121 | positive regulation of blood coagulation (GO:0030194) | 2.33517200 |
| 122 | regulation of early endosome to late endosome transport (GO:2000641) | 2.32825908 |
| 123 | positive regulation of extracellular matrix organization (GO:1903055) | 2.32473502 |
| 124 | T-helper 1 type immune response (GO:0042088) | 2.32319411 |
| 125 | protein-lipid complex assembly (GO:0065005) | 2.32309395 |
| 126 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.30595913 |
| 127 | regulation of macrophage cytokine production (GO:0010935) | 2.29307964 |
| 128 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.29167728 |
| 129 | protein retention in ER lumen (GO:0006621) | 2.28975877 |
| 130 | positive regulation of sterol transport (GO:0032373) | 2.28951463 |
| 131 | positive regulation of cholesterol transport (GO:0032376) | 2.28951463 |
| 132 | tricarboxylic acid metabolic process (GO:0072350) | 2.28769097 |
| 133 | regulation of nuclease activity (GO:0032069) | 2.27987194 |
| 134 | COPII vesicle coating (GO:0048208) | 2.27915323 |
| 135 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.27732816 |
| 136 | response to lipoprotein particle (GO:0055094) | 2.27301257 |
| 137 | protein localization to endosome (GO:0036010) | 2.27213433 |
| 138 | positive regulation of coagulation (GO:0050820) | 2.26600706 |
| 139 | regulation of fibrinolysis (GO:0051917) | 2.26376816 |
| 140 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.25921466 |
| 141 | basement membrane organization (GO:0071711) | 2.25880016 |
| 142 | tyrosine metabolic process (GO:0006570) | 2.25825749 |
| 143 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.25720046 |
| 144 | response to host immune response (GO:0052572) | 2.25720046 |
| 145 | wound healing, spreading of epidermal cells (GO:0035313) | 2.24349855 |
| 146 | glyoxylate metabolic process (GO:0046487) | 2.24226731 |
| 147 | complement activation, classical pathway (GO:0006958) | 2.23925340 |
| 148 | nitrogen cycle metabolic process (GO:0071941) | 2.23575263 |
| 149 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.23116397 |
| 150 | I-kappaB phosphorylation (GO:0007252) | 2.22908846 |
| 151 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.22869891 |
| 152 | cortical actin cytoskeleton organization (GO:0030866) | 2.22796619 |
| 153 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.22504887 |
| 154 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.22444701 |
| 155 | complement activation (GO:0006956) | 2.22265173 |
| 156 | membrane protein ectodomain proteolysis (GO:0006509) | 2.22089985 |
| 157 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.22021514 |
| 158 | kynurenine metabolic process (GO:0070189) | 2.21579293 |
| 159 | negative regulation of lipid transport (GO:0032369) | 2.21500808 |
| 160 | positive regulation of histone deacetylation (GO:0031065) | 2.21468178 |
| 161 | osteoclast differentiation (GO:0030316) | 2.20004776 |
| 162 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.19147273 |
| 163 | macrophage activation (GO:0042116) | 2.17526087 |
| 164 | substrate-dependent cell migration (GO:0006929) | 2.17233291 |
| 165 | bile acid biosynthetic process (GO:0006699) | 2.16858371 |
| 166 | cellular response to topologically incorrect protein (GO:0035967) | 2.16393680 |
| 167 | regulation of monocyte chemotaxis (GO:0090025) | 2.16141958 |
| 168 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.13562874 |
| 169 | regulation of extracellular matrix disassembly (GO:0010715) | 2.11693449 |
| 170 | positive regulation of macrophage cytokine production (GO:0060907) | 2.10427326 |
| 171 | regulation of mast cell degranulation (GO:0043304) | 2.09718292 |
| 172 | decidualization (GO:0046697) | 2.09019042 |
| 173 | glial cell migration (GO:0008347) | 2.07181058 |
| 174 | positive regulation of phagocytosis (GO:0050766) | 2.04811018 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.80642293 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.82579156 |
| 3 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.39840670 |
| 4 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.37950166 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.96884375 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.87345777 |
| 7 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.80388278 |
| 8 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.51290363 |
| 9 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.37248172 |
| 10 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.34206744 |
| 11 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.33803659 |
| 12 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.30047581 |
| 13 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.26540372 |
| 14 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.24534886 |
| 15 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.22772378 |
| 16 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.19897347 |
| 17 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.19139875 |
| 18 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.17780402 |
| 19 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.10294812 |
| 20 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.95601456 |
| 21 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.91176021 |
| 22 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.85102992 |
| 23 | GATA1_22025678_ChIP-Seq_K562_Human | 1.82840116 |
| 24 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.81231633 |
| 25 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.69891659 |
| 26 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.67535375 |
| 27 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.65192276 |
| 28 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.62929353 |
| 29 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.60671754 |
| 30 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.60574011 |
| 31 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.58634091 |
| 32 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.57968401 |
| 33 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.46814168 |
| 34 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.45589589 |
| 35 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.43119893 |
| 36 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.41591109 |
| 37 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.39532671 |
| 38 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.36508692 |
| 39 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.36500586 |
| 40 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.36436579 |
| 41 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.35578263 |
| 42 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.32745350 |
| 43 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.31774652 |
| 44 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.31666155 |
| 45 | SPI1_23127762_ChIP-Seq_K562_Human | 1.30183332 |
| 46 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.29744735 |
| 47 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.29744735 |
| 48 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.29368944 |
| 49 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.26869269 |
| 50 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.23962781 |
| 51 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.23603391 |
| 52 | GATA1_19941826_ChIP-Seq_K562_Human | 1.22283468 |
| 53 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.21884311 |
| 54 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.21050715 |
| 55 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.19846435 |
| 56 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.19353905 |
| 57 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.19353905 |
| 58 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.19004990 |
| 59 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.18489045 |
| 60 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.17659609 |
| 61 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.17626601 |
| 62 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.17401078 |
| 63 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.15978083 |
| 64 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.15396715 |
| 65 | CJUN_26792858_Chip-Seq_BT549_Human | 1.14094995 |
| 66 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.14053408 |
| 67 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.13898801 |
| 68 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.13210012 |
| 69 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.12242471 |
| 70 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.11862067 |
| 71 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.11688314 |
| 72 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.11688314 |
| 73 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.10730758 |
| 74 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.10471433 |
| 75 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.10355197 |
| 76 | * TFEB_21752829_ChIP-Seq_HELA_Human | 1.10061333 |
| 77 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.09659189 |
| 78 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.08901267 |
| 79 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.08188194 |
| 80 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.07464591 |
| 81 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.06859322 |
| 82 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.06338917 |
| 83 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.06037115 |
| 84 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.05484242 |
| 85 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.05461471 |
| 86 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.05351018 |
| 87 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.04394715 |
| 88 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.03411286 |
| 89 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.03210809 |
| 90 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.00579644 |
| 91 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.00490992 |
| 92 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.99068544 |
| 93 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.98876248 |
| 94 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.98250763 |
| 95 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.97363422 |
| 96 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.97239028 |
| 97 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.97216714 |
| 98 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.97075797 |
| 99 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.96649708 |
| 100 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96316221 |
| 101 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.95639709 |
| 102 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.94919681 |
| 103 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.94843397 |
| 104 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.93821975 |
| 105 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.92735045 |
| 106 | * KDM2B_26808549_Chip-Seq_K562_Human | 0.92115460 |
| 107 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.90745145 |
| 108 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.88618077 |
| 109 | * PU_27001747_Chip-Seq_BMDM_Mouse | 0.87861366 |
| 110 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.87549660 |
| 111 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.85156951 |
| 112 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.84405786 |
| 113 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.84057406 |
| 114 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.83989256 |
| 115 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.83430806 |
| 116 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.83260391 |
| 117 | ATF3_27146783_Chip-Seq_COLON_Human | 0.82889085 |
| 118 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.82397627 |
| 119 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.81835901 |
| 120 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.81752379 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005058_abnormal_lysosome_morphology | 3.89717425 |
| 2 | MP0008438_abnormal_cutaneous_collagen | 3.49532031 |
| 3 | MP0002139_abnormal_hepatobiliary_system | 3.38415474 |
| 4 | MP0009840_abnormal_foam_cell | 3.18702439 |
| 5 | MP0005360_urolithiasis | 3.07353985 |
| 6 | MP0003191_abnormal_cellular_cholesterol | 3.05003912 |
| 7 | MP0003705_abnormal_hypodermis_morpholog | 2.97997885 |
| 8 | MP0003172_abnormal_lysosome_physiology | 2.76491721 |
| 9 | MP0003300_gastrointestinal_ulcer | 2.75596070 |
| 10 | MP0005365_abnormal_bile_salt | 2.50468046 |
| 11 | MP0003252_abnormal_bile_duct | 2.44371594 |
| 12 | MP0005085_abnormal_gallbladder_physiolo | 2.14351373 |
| 13 | MP0005451_abnormal_body_composition | 2.14150836 |
| 14 | MP0003195_calcinosis | 2.02921984 |
| 15 | MP0003303_peritoneal_inflammation | 1.97414009 |
| 16 | MP0003828_pulmonary_edema | 1.95485246 |
| 17 | MP0010329_abnormal_lipoprotein_level | 1.91115915 |
| 18 | MP0008875_abnormal_xenobiotic_pharmacok | 1.89601014 |
| 19 | MP0005257_abnormal_intraocular_pressure | 1.87872696 |
| 20 | MP0001958_emphysema | 1.77845248 |
| 21 | MP0003566_abnormal_cell_adhesion | 1.75809347 |
| 22 | MP0002877_abnormal_melanocyte_morpholog | 1.72606522 |
| 23 | MP0003329_amyloid_beta_deposits | 1.68789176 |
| 24 | MP0006082_CNS_inflammation | 1.68554153 |
| 25 | MP0005275_abnormal_skin_tensile | 1.61733030 |
| 26 | MP0000604_amyloidosis | 1.59962149 |
| 27 | MP0009785_altered_susceptibility_to | 1.59297277 |
| 28 | MP0002148_abnormal_hypersensitivity_rea | 1.58554390 |
| 29 | MP0005083_abnormal_biliary_tract | 1.55204313 |
| 30 | MP0008004_abnormal_stomach_pH | 1.54688689 |
| 31 | MP0003279_aneurysm | 1.54010235 |
| 32 | MP0005670_abnormal_white_adipose | 1.46520379 |
| 33 | MP0003436_decreased_susceptibility_to | 1.46215798 |
| 34 | MP0000609_abnormal_liver_physiology | 1.43298074 |
| 35 | MP0008260_abnormal_autophagy | 1.40443910 |
| 36 | MP0009643_abnormal_urine_homeostasis | 1.39988168 |
| 37 | MP0005025_abnormal_response_to | 1.37675664 |
| 38 | MP0004883_abnormal_blood_vessel | 1.36565628 |
| 39 | MP0003448_altered_tumor_morphology | 1.35298446 |
| 40 | MP0005332_abnormal_amino_acid | 1.34825221 |
| 41 | MP0003690_abnormal_glial_cell | 1.34049575 |
| 42 | MP0006054_spinal_hemorrhage | 1.33463430 |
| 43 | MP0002118_abnormal_lipid_homeostasis | 1.33397911 |
| 44 | MP0004130_abnormal_muscle_cell | 1.33376993 |
| 45 | MP0001533_abnormal_skeleton_physiology | 1.30621088 |
| 46 | MP0002254_reproductive_system_inflammat | 1.29900315 |
| 47 | MP0000858_altered_metastatic_potential | 1.29898339 |
| 48 | MP0003045_fibrosis | 1.29391747 |
| 49 | MP0000685_abnormal_immune_system | 1.28417984 |
| 50 | MP0003075_altered_response_to | 1.28146043 |
| 51 | MP0002138_abnormal_hepatobiliary_system | 1.27718672 |
| 52 | MP0000569_abnormal_digit_pigmentation | 1.27445478 |
| 53 | MP0003183_abnormal_peptide_metabolism | 1.25075292 |
| 54 | MP0004510_myositis | 1.23506638 |
| 55 | MP0003950_abnormal_plasma_membrane | 1.22310057 |
| 56 | MP0002998_abnormal_bone_remodeling | 1.21506787 |
| 57 | MP0003453_abnormal_keratinocyte_physiol | 1.21348505 |
| 58 | MP0002909_abnormal_adrenal_gland | 1.21226236 |
| 59 | MP0008961_abnormal_basal_metabolism | 1.19053647 |
| 60 | MP0002419_abnormal_innate_immunity | 1.19040578 |
| 61 | MP0010352_gastrointestinal_tract_polyps | 1.17828251 |
| 62 | MP0005464_abnormal_platelet_physiology | 1.17575913 |
| 63 | MP0004185_abnormal_adipocyte_glucose | 1.17309364 |
| 64 | MP0001666_abnormal_nutrient_absorption | 1.16667853 |
| 65 | MP0004019_abnormal_vitamin_homeostasis | 1.16052459 |
| 66 | MP0001835_abnormal_antigen_presentation | 1.15713233 |
| 67 | MP0001756_abnormal_urination | 1.14903556 |
| 68 | MP0009780_abnormal_chondrocyte_physiolo | 1.14383992 |
| 69 | MP0005165_increased_susceptibility_to | 1.14290838 |
| 70 | MP0001542_abnormal_bone_strength | 1.13788810 |
| 71 | MP0002896_abnormal_bone_mineralization | 1.13531327 |
| 72 | MP0002452_abnormal_antigen_presenting | 1.12916267 |
| 73 | MP0003091_abnormal_cell_migration | 1.12524698 |
| 74 | MP0000013_abnormal_adipose_tissue | 1.11380022 |
| 75 | MP0002168_other_aberrant_phenotype | 1.10867524 |
| 76 | MP0005319_abnormal_enzyme/_coenzyme | 1.08671484 |
| 77 | MP0010368_abnormal_lymphatic_system | 1.07543217 |
| 78 | MP0002090_abnormal_vision | 1.05429750 |
| 79 | MP0005023_abnormal_wound_healing | 1.03284494 |
| 80 | MP0005076_abnormal_cell_differentiation | 1.02718505 |
| 81 | MP0008469_abnormal_protein_level | 1.01939783 |
| 82 | MP0004272_abnormal_basement_membrane | 1.01913059 |
| 83 | MP0001853_heart_inflammation | 1.01904488 |
| 84 | MP0000465_gastrointestinal_hemorrhage | 1.01342591 |
| 85 | MP0005666_abnormal_adipose_tissue | 1.01186151 |
| 86 | MP0009384_cardiac_valve_regurgitation | 1.00380745 |
| 87 | MP0001849_ear_inflammation | 0.99810527 |
| 88 | MP0004947_skin_inflammation | 0.99583090 |
| 89 | MP0002928_abnormal_bile_duct | 0.99441850 |
| 90 | MP0010234_abnormal_vibrissa_follicle | 0.98697446 |
| 91 | MP0000343_altered_response_to | 0.98452162 |
| 92 | MP0010155_abnormal_intestine_physiology | 0.97159808 |
| 93 | MP0002295_abnormal_pulmonary_circulatio | 0.96409970 |
| 94 | MP0003283_abnormal_digestive_organ | 0.95637492 |
| 95 | MP0002723_abnormal_immune_serum | 0.95274202 |
| 96 | MP0003656_abnormal_erythrocyte_physiolo | 0.94897834 |
| 97 | MP0005390_skeleton_phenotype | 0.94600566 |
| 98 | MP0002078_abnormal_glucose_homeostasis | 0.93939817 |
| 99 | MP0002405_respiratory_system_inflammati | 0.93147643 |
| 100 | MP0005409_darkened_coat_color | 0.92961531 |
| 101 | MP0005167_abnormal_blood-brain_barrier | 0.92854252 |
| 102 | MP0005375_adipose_tissue_phenotype | 0.91963278 |
| 103 | MP0001790_abnormal_immune_system | 0.91937565 |
| 104 | MP0005387_immune_system_phenotype | 0.91937565 |
| 105 | MP0002136_abnormal_kidney_physiology | 0.91797369 |
| 106 | MP0004233_abnormal_muscle_weight | 0.91536972 |
| 107 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.91242234 |
| 108 | MP0003724_increased_susceptibility_to | 0.90493298 |
| 109 | MP0000598_abnormal_liver_morphology | 0.89583569 |
| 110 | MP0005220_abnormal_exocrine_pancreas | 0.89553596 |
| 111 | MP0000767_abnormal_smooth_muscle | 0.89149374 |
| 112 | MP0002693_abnormal_pancreas_physiology | 0.88731259 |
| 113 | MP0001915_intracranial_hemorrhage | 0.88702273 |
| 114 | MP0005595_abnormal_vascular_smooth | 0.88189202 |
| 115 | MP0000920_abnormal_myelination | 0.84185516 |
| 116 | MP0004858_abnormal_nervous_system | 0.82983455 |
| 117 | MP0005166_decreased_susceptibility_to | 0.82733896 |
| 118 | MP0001944_abnormal_pancreas_morphology | 0.82628639 |
| 119 | MP0001845_abnormal_inflammatory_respons | 0.80367899 |
| 120 | MP0009278_abnormal_bone_marrow | 0.80116400 |
| 121 | MP0000003_abnormal_adipose_tissue | 0.79912841 |
| 122 | MP0000249_abnormal_blood_vessel | 0.79493219 |
| 123 | MP0001819_abnormal_immune_cell | 0.78787864 |
| 124 | MP0009764_decreased_sensitivity_to | 0.78495703 |
| 125 | MP0003634_abnormal_glial_cell | 0.78080648 |
| 126 | MP0002420_abnormal_adaptive_immunity | 0.78079890 |
| 127 | MP0005164_abnormal_response_to | 0.77892948 |
| 128 | MP0005334_abnormal_fat_pad | 0.77542840 |
| 129 | MP0002971_abnormal_brown_adipose | 0.77072810 |
| 130 | MP0005000_abnormal_immune_tolerance | 0.76793781 |
| 131 | MP0010386_abnormal_urinary_bladder | 0.76589289 |
| 132 | MP0005503_abnormal_tendon_morphology | 0.76491475 |
| 133 | MP0001851_eye_inflammation | 0.76074636 |
| 134 | MP0002837_dystrophic_cardiac_calcinosis | 0.75686617 |
| 135 | MP0005397_hematopoietic_system_phenotyp | 0.75624319 |
| 136 | MP0001545_abnormal_hematopoietic_system | 0.75624319 |
| 137 | MP0000371_diluted_coat_color | 0.74750608 |
| 138 | MP0005248_abnormal_Harderian_gland | 0.74340272 |
| 139 | MP0005671_abnormal_response_to | 0.73716539 |
| 140 | MP0002933_joint_inflammation | 0.73443672 |
| 141 | MP0003795_abnormal_bone_structure | 0.72470617 |
| 142 | MP0001800_abnormal_humoral_immune | 0.71876672 |
| 143 | MP0002332_abnormal_exercise_endurance | 0.68465376 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Systemic lupus erythematosus (HP:0002725) | 4.68090971 |
| 2 | Increased cerebral lipofuscin (HP:0011813) | 4.38684092 |
| 3 | Complement deficiency (HP:0004431) | 4.06399827 |
| 4 | Cerebral aneurysm (HP:0004944) | 3.78481683 |
| 5 | * Dysostosis multiplex (HP:0000943) | 3.75575410 |
| 6 | Vacuolated lymphocytes (HP:0001922) | 3.66903092 |
| 7 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.56977162 |
| 8 | Glomerulonephritis (HP:0000099) | 3.53985525 |
| 9 | * Mucopolysacchariduria (HP:0008155) | 3.49893623 |
| 10 | * Urinary glycosaminoglycan excretion (HP:0003541) | 3.49893623 |
| 11 | Deep venous thrombosis (HP:0002625) | 3.34867012 |
| 12 | Abnormality of glycolipid metabolism (HP:0010969) | 3.34220204 |
| 13 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.34220204 |
| 14 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.34220204 |
| 15 | * Abnormality of polysaccharide metabolism (HP:0011012) | 3.32049703 |
| 16 | * Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.32049703 |
| 17 | * Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.32049703 |
| 18 | Xanthomatosis (HP:0000991) | 3.20121136 |
| 19 | Abnormality of complement system (HP:0005339) | 3.16004305 |
| 20 | Myocardial infarction (HP:0001658) | 3.15837743 |
| 21 | Retinal atrophy (HP:0001105) | 2.91049916 |
| 22 | Aortic aneurysm (HP:0004942) | 2.84184958 |
| 23 | Premature rupture of membranes (HP:0001788) | 2.83998106 |
| 24 | Cervical subluxation (HP:0003308) | 2.82084273 |
| 25 | Protrusio acetabuli (HP:0003179) | 2.82053717 |
| 26 | Hypoglycemic coma (HP:0001325) | 2.74665007 |
| 27 | Axonal loss (HP:0003447) | 2.69895301 |
| 28 | Nephritis (HP:0000123) | 2.63602362 |
| 29 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.57574418 |
| 30 | Arterial tortuosity (HP:0005116) | 2.55610807 |
| 31 | Skin nodule (HP:0200036) | 2.52544226 |
| 32 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.52152936 |
| 33 | Mitral stenosis (HP:0001718) | 2.50968170 |
| 34 | Vascular tortuosity (HP:0004948) | 2.50709769 |
| 35 | Abnormality of the common coagulation pathway (HP:0010990) | 2.50593340 |
| 36 | Hematochezia (HP:0002573) | 2.49942202 |
| 37 | Aortic dissection (HP:0002647) | 2.48003871 |
| 38 | Intrahepatic cholestasis (HP:0001406) | 2.43686464 |
| 39 | Global brain atrophy (HP:0002283) | 2.43404927 |
| 40 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.41285129 |
| 41 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.39364842 |
| 42 | Hypoglycemic seizures (HP:0002173) | 2.39067550 |
| 43 | Aneurysm (HP:0002617) | 2.38503770 |
| 44 | Loss of speech (HP:0002371) | 2.35102475 |
| 45 | Hypoalphalipoproteinemia (HP:0003233) | 2.32681088 |
| 46 | Nuclear cataract (HP:0100018) | 2.32274041 |
| 47 | Ketoacidosis (HP:0001993) | 2.32142802 |
| 48 | Peritonitis (HP:0002586) | 2.29045083 |
| 49 | Striae distensae (HP:0001065) | 2.25791222 |
| 50 | Mitral valve prolapse (HP:0001634) | 2.23297425 |
| 51 | Interstitial pulmonary disease (HP:0006530) | 2.21810737 |
| 52 | Hydroxyprolinuria (HP:0003080) | 2.20796542 |
| 53 | Abnormality of proline metabolism (HP:0010907) | 2.20796542 |
| 54 | Ketosis (HP:0001946) | 2.20701632 |
| 55 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.18895110 |
| 56 | Spontaneous hematomas (HP:0007420) | 2.18450526 |
| 57 | Increased CSF protein (HP:0002922) | 2.16431250 |
| 58 | Orchitis (HP:0100796) | 2.16323953 |
| 59 | Gingivitis (HP:0000230) | 2.16184674 |
| 60 | Joint hemorrhage (HP:0005261) | 2.16040573 |
| 61 | Abnormality of the intrinsic pathway (HP:0010989) | 2.13672962 |
| 62 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.12766849 |
| 63 | Hyperlipoproteinemia (HP:0010980) | 2.12461928 |
| 64 | Upper motor neuron abnormality (HP:0002127) | 2.12390155 |
| 65 | Bone pain (HP:0002653) | 2.11739972 |
| 66 | Eczematoid dermatitis (HP:0000976) | 2.10574297 |
| 67 | Apathy (HP:0000741) | 2.08944304 |
| 68 | Progressive neurologic deterioration (HP:0002344) | 2.08638294 |
| 69 | Diminished motivation (HP:0000745) | 2.05925326 |
| 70 | Absent frontal sinuses (HP:0002688) | 2.04898966 |
| 71 | Spondylolisthesis (HP:0003302) | 2.04806789 |
| 72 | Sensorimotor neuropathy (HP:0007141) | 1.98202776 |
| 73 | Vertebral compression fractures (HP:0002953) | 1.98176273 |
| 74 | Disproportionate tall stature (HP:0001519) | 1.97210190 |
| 75 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.96576550 |
| 76 | Hand muscle atrophy (HP:0009130) | 1.96518855 |
| 77 | Abnormality of purine metabolism (HP:0004352) | 1.96248600 |
| 78 | Purpura (HP:0000979) | 1.95702480 |
| 79 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.95276416 |
| 80 | Osteolytic defects of the hand bones (HP:0009699) | 1.95276416 |
| 81 | Shallow orbits (HP:0000586) | 1.95088573 |
| 82 | Esophageal varix (HP:0002040) | 1.94568479 |
| 83 | Epidermoid cyst (HP:0200040) | 1.93775509 |
| 84 | Myositis (HP:0100614) | 1.93436718 |
| 85 | Turricephaly (HP:0000262) | 1.91613513 |
| 86 | Tetraparesis (HP:0002273) | 1.91411964 |
| 87 | Recurrent bacterial skin infections (HP:0005406) | 1.91245286 |
| 88 | Dilatation of the ascending aorta (HP:0005111) | 1.90849706 |
| 89 | Wormian bones (HP:0002645) | 1.90044418 |
| 90 | Amyloidosis (HP:0011034) | 1.89892284 |
| 91 | Autoimmune thrombocytopenia (HP:0001973) | 1.89721541 |
| 92 | Protuberant abdomen (HP:0001538) | 1.88749301 |
| 93 | Broad metatarsal (HP:0001783) | 1.88540036 |
| 94 | Upper limb amyotrophy (HP:0009129) | 1.88168784 |
| 95 | Distal upper limb amyotrophy (HP:0007149) | 1.88168784 |
| 96 | Hyperglycemia (HP:0003074) | 1.85724242 |
| 97 | Abnormality of macrophages (HP:0004311) | 1.85238811 |
| 98 | Neurofibrillary tangles (HP:0002185) | 1.84674133 |
| 99 | Hypercholesterolemia (HP:0003124) | 1.82960177 |
| 100 | Long toe (HP:0010511) | 1.82389376 |
| 101 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.82123826 |
| 102 | Thoracic kyphosis (HP:0002942) | 1.82105763 |
| 103 | Cardiomegaly (HP:0001640) | 1.81306789 |
| 104 | Cerebral inclusion bodies (HP:0100314) | 1.80371779 |
| 105 | Neuronal loss in central nervous system (HP:0002529) | 1.79462847 |
| 106 | Late onset (HP:0003584) | 1.77804501 |
| 107 | J-shaped sella turcica (HP:0002680) | 1.76274778 |
| 108 | Blue sclerae (HP:0000592) | 1.75280834 |
| 109 | Thin bony cortex (HP:0002753) | 1.75167670 |
| 110 | Recurrent abscess formation (HP:0002722) | 1.74812772 |
| 111 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.74797991 |
| 112 | Hypolipoproteinemia (HP:0010981) | 1.74778001 |
| 113 | Short nail (HP:0001799) | 1.74745773 |
| 114 | Retrobulbar optic neuritis (HP:0100654) | 1.73830960 |
| 115 | Optic neuritis (HP:0100653) | 1.73830960 |
| 116 | Polycythemia (HP:0001901) | 1.73762013 |
| 117 | Disinhibition (HP:0000734) | 1.73517621 |
| 118 | Mediastinal lymphadenopathy (HP:0100721) | 1.73446069 |
| 119 | Malnutrition (HP:0004395) | 1.73230406 |
| 120 | Pathologic fracture (HP:0002756) | 1.72826778 |
| 121 | Lymphangioma (HP:0100764) | 1.72322531 |
| 122 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.71502144 |
| 123 | Hepatosplenomegaly (HP:0001433) | 1.71090830 |
| 124 | * Asymmetric septal hypertrophy (HP:0001670) | 1.68204761 |
| 125 | Conjunctival telangiectasia (HP:0000524) | 1.67864796 |
| 126 | Flat acetabular roof (HP:0003180) | 1.66266089 |
| 127 | Mutism (HP:0002300) | 1.64092256 |
| 128 | Gingival bleeding (HP:0000225) | 1.64089033 |
| 129 | Subacute progressive viral hepatitis (HP:0006572) | 1.62726171 |
| 130 | Abnormality of the periventricular white matter (HP:0002518) | 1.62649733 |
| 131 | Metaphyseal irregularity (HP:0003025) | 1.62564508 |
| 132 | Recurrent skin infections (HP:0001581) | 1.62244566 |
| 133 | Prolonged neonatal jaundice (HP:0006579) | 1.62081832 |
| 134 | * Ovoid vertebral bodies (HP:0003300) | 1.61883680 |
| 135 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.60129206 |
| 136 | Ankle contracture (HP:0006466) | 1.58524057 |
| 137 | Flared iliac wings (HP:0002869) | 1.57815173 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 4.47560817 |
| 2 | TRIB3 | 4.09954727 |
| 3 | TGFBR2 | 3.41385919 |
| 4 | PKN2 | 2.89866673 |
| 5 | SIK1 | 2.55143038 |
| 6 | TAOK3 | 2.24991774 |
| 7 | PRPF4B | 2.24155246 |
| 8 | PTK6 | 2.09482839 |
| 9 | CAMK1D | 2.08535677 |
| 10 | INSRR | 1.93936387 |
| 11 | EPHB1 | 1.90222354 |
| 12 | PDGFRA | 1.88579333 |
| 13 | RIPK1 | 1.86251180 |
| 14 | FGFR4 | 1.85547063 |
| 15 | JAK1 | 1.83577727 |
| 16 | TYK2 | 1.82873502 |
| 17 | TTN | 1.75321098 |
| 18 | SCYL2 | 1.74571881 |
| 19 | TBK1 | 1.72955810 |
| 20 | CAMK1G | 1.65517583 |
| 21 | MAP3K10 | 1.43881949 |
| 22 | GRK7 | 1.41827009 |
| 23 | MAPK15 | 1.38589254 |
| 24 | IRAK3 | 1.36320595 |
| 25 | EPHA3 | 1.31456244 |
| 26 | FRK | 1.30820955 |
| 27 | CSF1R | 1.28051604 |
| 28 | LATS1 | 1.27445031 |
| 29 | TAOK2 | 1.26730547 |
| 30 | BCKDK | 1.26517318 |
| 31 | NEK9 | 1.22204622 |
| 32 | FGR | 1.21187335 |
| 33 | MAP3K2 | 1.19789057 |
| 34 | ICK | 1.19702813 |
| 35 | DDR2 | 1.18592173 |
| 36 | TIE1 | 1.15829618 |
| 37 | LRRK2 | 1.14218940 |
| 38 | PTK2 | 1.13470994 |
| 39 | TRPM7 | 1.13120309 |
| 40 | BLK | 1.12952164 |
| 41 | JAK2 | 1.11904691 |
| 42 | TESK1 | 1.11449459 |
| 43 | PAK4 | 1.10737426 |
| 44 | IRAK4 | 1.08520016 |
| 45 | BMX | 1.07163050 |
| 46 | KIT | 1.06340005 |
| 47 | MST1R | 1.05774142 |
| 48 | FLT3 | 1.02239051 |
| 49 | MATK | 0.96877723 |
| 50 | MAP2K3 | 0.96872022 |
| 51 | FGFR3 | 0.96323350 |
| 52 | LATS2 | 0.95208229 |
| 53 | RET | 0.94751584 |
| 54 | PRKCH | 0.93514793 |
| 55 | MAP3K1 | 0.91946581 |
| 56 | ZAP70 | 0.91807354 |
| 57 | BMPR2 | 0.91433536 |
| 58 | MAP4K1 | 0.89726764 |
| 59 | CSK | 0.89308603 |
| 60 | CAMKK1 | 0.88915647 |
| 61 | MAP3K3 | 0.86734020 |
| 62 | CAMKK2 | 0.86387839 |
| 63 | MYLK | 0.85933311 |
| 64 | MAP3K6 | 0.85583873 |
| 65 | KSR2 | 0.84445464 |
| 66 | EPHB2 | 0.83838823 |
| 67 | MAP3K11 | 0.80691979 |
| 68 | PDGFRB | 0.79666911 |
| 69 | TAOK1 | 0.78647087 |
| 70 | PAK2 | 0.78128083 |
| 71 | JAK3 | 0.76360637 |
| 72 | FER | 0.75212171 |
| 73 | NTRK1 | 0.74931336 |
| 74 | MET | 0.74796478 |
| 75 | HCK | 0.74044091 |
| 76 | EEF2K | 0.73731668 |
| 77 | MTOR | 0.71459053 |
| 78 | PRKG2 | 0.70666529 |
| 79 | YES1 | 0.70101707 |
| 80 | RIPK4 | 0.69843235 |
| 81 | IRAK1 | 0.69438328 |
| 82 | CDK6 | 0.69063006 |
| 83 | PDPK1 | 0.68829064 |
| 84 | PRKD2 | 0.68397628 |
| 85 | MAP3K13 | 0.68293018 |
| 86 | HIPK2 | 0.67740956 |
| 87 | GSK3A | 0.67712020 |
| 88 | AKT3 | 0.66601373 |
| 89 | IRAK2 | 0.66494641 |
| 90 | MAP3K14 | 0.63718334 |
| 91 | NME2 | 0.62905609 |
| 92 | PIK3CG | 0.62842103 |
| 93 | LIMK1 | 0.62547230 |
| 94 | DYRK1B | 0.62098395 |
| 95 | MAP3K5 | 0.61288727 |
| 96 | FES | 0.61153779 |
| 97 | MAPK7 | 0.59603488 |
| 98 | MAP3K12 | 0.58528810 |
| 99 | SGK3 | 0.57936069 |
| 100 | PIM2 | 0.57754166 |
| 101 | PRKD3 | 0.57732546 |
| 102 | PRKD1 | 0.57680141 |
| 103 | EGFR | 0.57065532 |
| 104 | ERBB4 | 0.56024305 |
| 105 | STK10 | 0.55674292 |
| 106 | MOS | 0.55655754 |
| 107 | ACVR1B | 0.54596686 |
| 108 | MARK2 | 0.53728157 |
| 109 | STK38 | 0.52847056 |
| 110 | STK3 | 0.51980253 |
| 111 | ARAF | 0.51641235 |
| 112 | PDK2 | 0.51609076 |
| 113 | MAP2K1 | 0.51393076 |
| 114 | IGF1R | 0.51363176 |
| 115 | WNK4 | 0.50370828 |
| 116 | PDK1 | 0.49815285 |
| 117 | KSR1 | 0.49007697 |
| 118 | DMPK | 0.48291669 |
| 119 | ABL2 | 0.47221481 |
| 120 | CHUK | 0.46794890 |
| 121 | PAK3 | 0.46285015 |
| 122 | MARK3 | 0.43837451 |
| 123 | ITK | 0.42893185 |
| 124 | PRKAA2 | 0.42653970 |
| 125 | INSR | 0.42172666 |
| 126 | RPS6KA4 | 0.40808599 |
| 127 | RPS6KA2 | 0.40377382 |
| 128 | IKBKE | 0.39145472 |
| 129 | ABL1 | 0.37503310 |
| 130 | CDK12 | 0.37417265 |
| 131 | MAP3K9 | 0.36970938 |
| 132 | IKBKB | 0.36519269 |
| 133 | SRC | 0.36183633 |
| 134 | SIK2 | 0.35177057 |
| 135 | PTK2B | 0.34555399 |
| 136 | KDR | 0.34339582 |
| 137 | CDC42BPA | 0.33896679 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.84219001 |
| 2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.75513235 |
| 3 | * Lysosome_Homo sapiens_hsa04142 | 2.51224383 |
| 4 | * Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.35275201 |
| 5 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.28230656 |
| 6 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.15139372 |
| 7 | Other glycan degradation_Homo sapiens_hsa00511 | 2.06633597 |
| 8 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.97154982 |
| 9 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.93820704 |
| 10 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.90582131 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.72303183 |
| 12 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.69458655 |
| 13 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.67136650 |
| 14 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.66631692 |
| 15 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.55089349 |
| 16 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.50603881 |
| 17 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.36366338 |
| 18 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.32837218 |
| 19 | Bile secretion_Homo sapiens_hsa04976 | 1.26006252 |
| 20 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.23716314 |
| 21 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.21246080 |
| 22 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.16020913 |
| 23 | ABC transporters_Homo sapiens_hsa02010 | 1.15834643 |
| 24 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.11908782 |
| 25 | Salmonella infection_Homo sapiens_hsa05132 | 1.10347604 |
| 26 | Prion diseases_Homo sapiens_hsa05020 | 1.08804583 |
| 27 | Insulin resistance_Homo sapiens_hsa04931 | 1.07221320 |
| 28 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.06084175 |
| 29 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.05012603 |
| 30 | Hepatitis C_Homo sapiens_hsa05160 | 1.00918231 |
| 31 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.00152472 |
| 32 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.00051137 |
| 33 | Influenza A_Homo sapiens_hsa05164 | 0.99978470 |
| 34 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.98270583 |
| 35 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.97300521 |
| 36 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.97124888 |
| 37 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.96764968 |
| 38 | Leishmaniasis_Homo sapiens_hsa05140 | 0.95871532 |
| 39 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.95442622 |
| 40 | Peroxisome_Homo sapiens_hsa04146 | 0.95290484 |
| 41 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.93995009 |
| 42 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.92889905 |
| 43 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.92396451 |
| 44 | Pertussis_Homo sapiens_hsa05133 | 0.91684362 |
| 45 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.90947507 |
| 46 | Amoebiasis_Homo sapiens_hsa05146 | 0.90328626 |
| 47 | Tuberculosis_Homo sapiens_hsa05152 | 0.89773818 |
| 48 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.89089529 |
| 49 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.88812764 |
| 50 | Histidine metabolism_Homo sapiens_hsa00340 | 0.88601610 |
| 51 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.88382538 |
| 52 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.88256120 |
| 53 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.88071062 |
| 54 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.87424572 |
| 55 | Phagosome_Homo sapiens_hsa04145 | 0.87275743 |
| 56 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.85984323 |
| 57 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.83876143 |
| 58 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.83402585 |
| 59 | Lysine degradation_Homo sapiens_hsa00310 | 0.83337847 |
| 60 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.82671475 |
| 61 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.82529055 |
| 62 | Allograft rejection_Homo sapiens_hsa05330 | 0.81731195 |
| 63 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.81351661 |
| 64 | Hepatitis B_Homo sapiens_hsa05161 | 0.80399384 |
| 65 | Viral myocarditis_Homo sapiens_hsa05416 | 0.79000592 |
| 66 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.78729597 |
| 67 | Malaria_Homo sapiens_hsa05144 | 0.78062396 |
| 68 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.76430386 |
| 69 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.75605874 |
| 70 | Measles_Homo sapiens_hsa05162 | 0.75299443 |
| 71 | Shigellosis_Homo sapiens_hsa05131 | 0.75038906 |
| 72 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.74384831 |
| 73 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.71695998 |
| 74 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.70919899 |
| 75 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.70804369 |
| 76 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.70580351 |
| 77 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.70572365 |
| 78 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.70534442 |
| 79 | Focal adhesion_Homo sapiens_hsa04510 | 0.70343852 |
| 80 | Apoptosis_Homo sapiens_hsa04210 | 0.70136177 |
| 81 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.69749585 |
| 82 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.67795450 |
| 83 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.67483194 |
| 84 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.67095036 |
| 85 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.66892476 |
| 86 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.66402047 |
| 87 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.65808828 |
| 88 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.65695206 |
| 89 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.65177878 |
| 90 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.64281711 |
| 91 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.64150964 |
| 92 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.63742371 |
| 93 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.63330041 |
| 94 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.61342815 |
| 95 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.61131918 |
| 96 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.60936110 |
| 97 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.59869867 |
| 98 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.58692727 |
| 99 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.58482892 |
| 100 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.58141122 |
| 101 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.56586821 |
| 102 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.56008620 |
| 103 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.55274486 |
| 104 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.55119944 |
| 105 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.54929575 |
| 106 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.54714446 |
| 107 | Asthma_Homo sapiens_hsa05310 | 0.54039138 |
| 108 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.53136493 |
| 109 | Mineral absorption_Homo sapiens_hsa04978 | 0.53079626 |
| 110 | Endometrial cancer_Homo sapiens_hsa05213 | 0.52820742 |
| 111 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.52030143 |
| 112 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.51995251 |
| 113 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.51953483 |
| 114 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.51338769 |
| 115 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.50938275 |
| 116 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.50935556 |
| 117 | Galactose metabolism_Homo sapiens_hsa00052 | 0.50120043 |
| 118 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.49778660 |
| 119 | Legionellosis_Homo sapiens_hsa05134 | 0.49551320 |
| 120 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.49080573 |
| 121 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.48868988 |
| 122 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.47819888 |
| 123 | Adherens junction_Homo sapiens_hsa04520 | 0.47323085 |
| 124 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.47271979 |
| 125 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.47004773 |
| 126 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.46468863 |
| 127 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.46439326 |
| 128 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.46387956 |
| 129 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.44678292 |
| 130 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.44105535 |
| 131 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.43784384 |
| 132 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.43031017 |
| 133 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.42497307 |
| 134 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.41840868 |
| 135 | Prostate cancer_Homo sapiens_hsa05215 | 0.41295593 |
| 136 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.41043237 |
| 137 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.40966068 |
| 138 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.40773208 |
| 139 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.39737453 |
| 140 | Endocytosis_Homo sapiens_hsa04144 | 0.38944029 |
| 141 | Carbon metabolism_Homo sapiens_hsa01200 | 0.37535864 |
| 142 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.37368709 |
| 143 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.37172269 |
| 144 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.37005274 |
| 145 | Platelet activation_Homo sapiens_hsa04611 | 0.36923797 |
| 146 | Bladder cancer_Homo sapiens_hsa05219 | 0.35979620 |
| 147 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.35864692 |
| 148 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.34529391 |

